ZYNERBA PHARMACEUTICALS INC's ticker is and the CUSIP is 98986X959. A total of 3 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | – | 900 | -10.0% | 0.00% | – |
Q4 2022 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 1,000 | -83.3% | 0.00% | – |
Q2 2022 | $6,000 | -71.4% | 6,000 | -41.7% | 0.00% | – |
Q1 2022 | $21,000 | -30.0% | 10,300 | -2.8% | 0.00% | – |
Q4 2021 | $30,000 | -60.0% | 10,600 | -24.8% | 0.00% | – |
Q3 2021 | $75,000 | +1.4% | 14,100 | 0.0% | 0.00% | – |
Q2 2021 | $74,000 | – | 14,100 | +3630.2% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 378 | +133.3% | 0.00% | – |
Q4 2020 | $53,000 | +3.9% | 162 | +4.5% | 0.00% | – |
Q3 2020 | $51,000 | -91.3% | 155 | -91.1% | 0.00% | -100.0% |
Q2 2020 | $587,000 | +8285.7% | 1,744 | +9078.9% | 0.00% | – |
Q1 2020 | $7,000 | -96.3% | 19 | -93.9% | 0.00% | – |
Q4 2019 | $187,000 | -54.7% | 310 | -43.3% | 0.00% | -100.0% |
Q3 2019 | $413,000 | +188.8% | 547 | +416.0% | 0.00% | – |
Q2 2019 | $143,000 | +90.7% | 106 | -24.3% | 0.00% | – |
Q1 2019 | $75,000 | +837.5% | 140 | +366.7% | 0.00% | – |
Q4 2018 | $8,000 | -91.3% | 30 | -73.5% | 0.00% | – |
Q3 2018 | $92,000 | +338.1% | 113 | +413.6% | 0.00% | – |
Q2 2018 | $21,000 | +61.5% | 22 | -33.3% | 0.00% | -100.0% |
Q1 2018 | $13,000 | +85.7% | 33 | -83.2% | 0.00% | – |
Q4 2017 | $7,000 | -41.7% | 197 | -8.8% | 0.00% | – |
Q3 2017 | $12,000 | -69.2% | 216 | +87.8% | 0.00% | -100.0% |
Q2 2017 | $39,000 | -61.4% | 115 | -63.0% | 0.00% | -50.0% |
Q1 2017 | $101,000 | +10000.0% | 311 | +2727.3% | 0.00% | – |
Q4 2016 | $1,000 | – | 11 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 59,200 | $275,000 | 0.00% |
SIMPLEX TRADING, LLC | 378 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |